Alerts & notifications
-
Highly potent synthetic opioid detected in fake diazepam tabletNotification|06 May 2024
UPDATED 6 May 2024
A highly potent synthetic opioid, N-Desethyletonitazene, has been detected in a fake benzodiazepine tablets. -
Synthetic Cannabinoid misrepresented as DMTNotification|03 May 2024
UPDATED 3 May 2024
Synthetic Cannabinoid MDMB-4en-PINACA has been detected in a yellow powder presumed to be DMT -
Alpha-PVP like substance misrepresented as MDMA in ChristchurchNotification|27 December 2023
UPDATED 4 January 2024
An Alpha-PVP like substance has been detected in a brown powder presumed to be MDMA in the Christchurch region. -
Heroin sold as ketamine in Auckland regionNotification|25 November 2023
Heroin has been found in a white powder that was sold as ketamine in the Auckland region.
-
Highly potent synthetic opioid misrepresented as butonitazeneNotification|03 November 2023
More highly potent nitazene variations have been identified.
-
Fake oxycodone tablets linked to serious harmNotification|27 September 2023
Fake oxycodone tablets, containing metonitazene, may be linked to a recent death and serious hospitalisations in New Zealand
-
Potent stimulant Alpha-PVP misrepresented as MDMANotification|06 April 2023
An off-white powder being sold as MDMA in Auckland has been found to contain Alpha-PVP.
-
Synthetic cannabinoid harm in Christchurch linked to hospitalisationsNotification|10 November 2022
A particularly dangerous batch of synthetic cannabinoids has been linked to serious harm in Christchurch in November 2022.
-
Yellow tablet/powder containing potent opioid likely to cause serious harmNotification|21 October 2022
UPDATED 28 MARCH 2023
Serious harm has been identified in relation to metonitazene found in a yellow powder. High Alert urges continued caution, particularly in the Auckland region. -
Potential adulteration of GBL in AucklandNotification|14 April 2022
We've identified harm linked to the potential adulteration of GBL and GBL-type substances in Auckland.